Clinical Trials on Vasomotor Symptoms (VMS) in France

Total 21277 results

Pfizer

Completed

The Effect Of Dose Titration And Dose Tapering On The Tolerability Of DVS SR In Women With Vasomotor Symptoms

Vasomotor Symptoms

Canada, United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause

Vasomotor Symptoms

United States
Astellas Pharma Global Development, Inc.

Completed

A Study of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause (Daylight)

Vasomotor Symptoms

Poland, Spain, Belgium, Canada, Czechia, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Norway, Sweden, Turkey, United Kingdom
Bayer

Completed

Low-dose Hormone Therapy for Relief of Vasomotor Symptoms

Vasomotor Symptoms | Hot Flashes

United States
Novo Nordisk A/S

Completed

Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations (CHOICE)

Menopause | Menopausal Vasomotor Symptoms

Denmark, United Kingdom, Sweden, Belgium, Switzerland, Germany, France, Finland, Austria, Norway
GlaxoSmithKline

Completed

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis

Vasomotor Rhinitis | Rhinitis, Vasomotor

United States, Romania, Czechia, Canada, Germany, Puerto Rico, Norway
University Hospital, Grenoble
Centre National de la Recherche Scientifique, France

Completed

Cortical Excitability Using Robotised and Neuronavigated Transcranial Magnetic Stimulation (ROBEXCI)

Cortical Excitability | Robotized TMS

France
University Hospital, Tours
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Validation of the French Version of the Geriatric Mental State (GMS) (GMS-Package)

Validate the French Version of GMS Package

France
University Hospital, Clermont-Ferrand

Completed

Intraoperative Protective Ventilation in Abdominal Surgery (IMPROVE Study)

Protective Lung Ventilation Using: | Low Tidal Volume (6-8 mL/kg Predicted Body Weight) | PEEP of 6-8 cmH2O | Intraoperative RMs

France
Central Hospital, Nancy, France

Not yet recruiting

Steroids Versus ECP and Steroids as First-line Treatment of Grade II Acute GVHD (COPAVEHDI)

Graft Vs Host Disease

France
Centre Hospitalier Universitaire de Nice

Completed

Automated EDSS Score Calculation by Smartphone Application (Easy EDSS)

MS CHRONIC PROGRESSIVE

France
Centre Hospitalier Universitaire de Nīmes

Completed

Prostate Embolization in Chronically Surveyed Patients: Effectiveness of Unilateral vs. Bilateral Embolization

Unilateral vs Bilateral Embolization of the Prostate Arteries

France
Centre Hospitalier Universitaire, Amiens

Unknown

Analysis of Transcriptomic Profile of Graft-versus-host Disease (GHVD) After Allogeneic Grafting of Hematopoietic Stem Cells

Graft Vs Host Disease | Hematopoietic Stem Cells

France
Bayer

Active, not recruiting

A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer (OASIS-4)

Hot Flashes | Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer

Spain, France, Belgium, United Kingdom, Hungary, Israel, Italy, Ireland, Germany, Portugal, Finland, Poland, Romania, Canada, Austria, Kazakhstan
Assistance Publique - Hôpitaux de Paris

Completed

Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT (ATG-CyGVHD)

Graft vs Host Disease

France
GeNeuro Innovation SAS

Completed

Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease (LOMBARD)

Multiple Sclerosis (MS) | Clinically Isolated Syndrome (CIS) | Secondary Progressive MS | Primary Progressive MS | Relapsing-Remitting MS

France, Spain, Switzerland
Centre Hospitalier Universitaire de Besancon

Recruiting

MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy (MORPHEE)

Cutaneous T-Cell Lymphoma | Graft Rejection | Graft Vs Host Disease

France
Nantes University Hospital

Terminated

Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRIC (CYRIC)

Graft Versus Host Disease

France
Assistance Publique Hopitaux De Marseille

Unknown

Characterization of Cortical Injury in Early MS Patients: a 7T MRI Study

Multiple Sclerosis (MS)

France
Assistance Publique - Hôpitaux de Paris
National Research Agency, France

Unknown

Toward Immune Biomarkers for Tolerance and GvHD in Humans (BioGvHD)

Bone Marrow Transplantation | Hematopoietic Stem Cell Transplantation | Graft vs Host Disease

France
Centre Hospitalier Universitaire de Besancon

Not yet recruiting

Impact of the Experience of Anaesthetists in Changing Ventilation Strategies During Panendoscopy on the Incidence of Intraoperative Hypoxaemia

ENT Tumor

France
Assistance Publique - Hôpitaux de Paris
Agence de La Biomédecine

Completed

Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell Transplantation (CALCICLO)

Hematopoietic Stem Cell Transplantation | Graft Versus Host Disease

France
University Hospital, Caen

Unknown

Evaluation of the Diagnostic Value of PET (18F-FDG) in Chronic Graft Versus Host Disease (cGVH) (TEP-GVH)

Chronic Graft Versus Host Disease

France
Nantes University Hospital

Completed

Study of First Line Treatment of Chronic Graft Versus Host Disease With the Association of Ciclosporine, Corticosteroids and Rituximab (Protocol R-GVHD) (R-GVHD)

Graft Versus Host Disease

France
Centre Hospitalier Universitaire de Besancon

Not yet recruiting

Comparison of HFNO and FMV on Desaturations During Panendoscopy Under General Anesthesia

ENT Tumor

France
Assistance Publique - Hôpitaux de Paris

Unknown

Physical Capacity and Rehabilitation of Patients With Multiple Sclerosis (REHABSEP)

Multiple Sclerosis (MS)

France
University Hospital, Lille

Recruiting

Dynamic of Immunocompetent Populations in Patients Treated With Extracorporeal Photopheresis in Chronic Graft Versus Host Disease (IMMUNO-PEC)

Graft Versus Host Disease | Extracorporeal Photopheresis

France
Nantes University Hospital

Completed

Early Detection of Mucosal Abnormalities in Graft-versus-host Disease (E-mage)

Graft Versus Host Disease

France
Centre Hospitalier Universitaire de Besancon

Unknown

Multimarker Approach for Acute Dyspnea in Elderly Patients Admitted in the Emergency Department (READ-MA)

Acute Heart Failure | Acute Dyspnea

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis (IMAGINDEALinMS)

Multiple Sclerosis (MS)

France
University Hospital, Clermont-Ferrand

Unknown

Extracorporeal Photopheresis in Children and Young Adults With Refractory Acute Graft Versus Host Disease

Graft Versus Host Disease

France
Assistance Publique - Hôpitaux de Paris

Unknown

Biomarkers for Acute Graft-versus-host Disease (PLASMA-INCA)

Acute GVH Disease

France
Assistance Publique - Hôpitaux de Paris
European Georges Pompidou Hospital; Clinical haematology and BMT unit,Necker... and other collaborators

Completed

Complement and Graft-versus-host Disease

Allografted With Myeloablative Conditioning

France
Imagine Institute

Terminated

Evaluation of a Kit for the Prediction of the Risk of Graft Versus Host Disease (Predictor007)

Hemopathy

France
Centre Hospitalier Universitaire de Besancon

Completed

Interest of the Addition of Docetaxel to Standard Treatment in First-line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients (TandHER)

Metastatic Cancer | HER2-positive Gastric Cancer | Docetaxel | Trastuzumab

France
Centre Hospitalier Universitaire de Besancon

Recruiting

Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disease After Allogeneic Stem Cell Transplantation (MetAlloLip)

Hematologic Diseases | Stem Cell Transplantation

France
ElsaLys Biotech

Available

Early Access Program With Inolimomab in Steroid-refractory Acute Graft Versus Host Disease

Steroid Resistant Acute Graft Versus Host Disease

France
Centre Hospitalier Universitaire de Besancon

Terminated

Comparison Between High-density Electroencephalography and Conventional Electroencephalography for Comatose Patients (COMETIQUE)

Post Anoxic Coma

France
University Hospital, Strasbourg, France

Completed

Microparticles and Bronchiolitis Obliterans Syndrome (MIBO)

Bronchiolitis Obliterans

France
Centre Hospitalier Universitaire de Besancon
Institut National de la Santé Et de la Recherche Médicale, France; Etablissement... and other collaborators

Completed

Cryotherapy and Doppler in Inflammatory Rheumatic Diseases (CDRI)

Rheumatoid Arthritis | Spondyloarthritis | Crystal-induced Arthritides

France
Centre Hospitalier Universitaire de Besancon

Completed

Wind Instruments' Fungal Contamination

Hypersensitivity Pneumonitis | Immunologically-induced Lung Disease

France
Centre Hospitalier Universitaire de Besancon

Completed

Requests for Euthanasia and Assisted Suicide in Establishment of Accommodation for Dependent Old Persons. (DESAGE)

Aging | Euthanasia | Assisted Suicide | Qualitative Research

France
Centre Hospitalier Universitaire de Besancon
Maison Médicale Jeanne Garnier

Completed

Requests for Euthanasia and Assisted Suicide (DESA)

Palliative Care | End of Life | Euthanasia | Assisted Suicide | Qualitative Research

France
Centre Hospitalier Universitaire de Besancon
University Hospital, Geneva; UMC Utrecht; University of Oxford; University Hospital... and other collaborators

Completed

Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities (MODERN)

Enterobacteriaceae Infections | Resistance Bacterial

France
University Hospital, Brest

Not yet recruiting

Establishment of a Primary Epididymal Cell Model From Epididymal Samples to Study CFTR Gene Regulation (CFTR-EP)

Cystic Fibrosis | Congenital Bilateral Absence of Vas Deferens | Sterility, Male

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Nintedanib in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome Grade 0p-1-2 (INFINITx-BOS)

Lung-transplant Recipients

France
Centre Hospitalier Universitaire de Besancon

Completed

Microcirculation During Extracorporeal Circulation (CITRON4)

Mesenteric Ischemia

France
Centre Hospitalier Universitaire de Besancon

Not yet recruiting

Influence of Air Pollution on SPondyloarthritis Flare-ups and Resistance to Treatment (SPAIR)

Spondyloarthritis, Axial

France
Assistance Publique - Hôpitaux de Paris

Active, not recruiting

To Compare the Efficacy of the Addition of Methotrexate (MTX) to Current Standard Acute Graft-versus-host Disease (GVHD) First-line Treatment With Corticosteroids (MTX-aGVHD)

Stem Cell Transplant Complications | GVHD, Acute | GVH - Graft Versus Host Reaction | Allogeneic Disease

France
University Hospital, Bordeaux

Recruiting

Tissue Immune Landscape of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation (TIL-GVHD) (TIL-GVHD)

Chronic Graft Versus Host Disease

France

Clinical Trials on Vasomotor Symptoms (VMS) in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations